Correlation Between Erytech Pharma and Janux Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Erytech Pharma and Janux Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erytech Pharma and Janux Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erytech Pharma SA and Janux Therapeutics, you can compare the effects of market volatilities on Erytech Pharma and Janux Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erytech Pharma with a short position of Janux Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erytech Pharma and Janux Therapeutics.

Diversification Opportunities for Erytech Pharma and Janux Therapeutics

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Erytech and Janux is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Erytech Pharma SA and Janux Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Janux Therapeutics and Erytech Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erytech Pharma SA are associated (or correlated) with Janux Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Janux Therapeutics has no effect on the direction of Erytech Pharma i.e., Erytech Pharma and Janux Therapeutics go up and down completely randomly.

Pair Corralation between Erytech Pharma and Janux Therapeutics

If you would invest  78.00  in Erytech Pharma SA on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Erytech Pharma SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.76%
ValuesDaily Returns

Erytech Pharma SA  vs.  Janux Therapeutics

 Performance 
       Timeline  
Erytech Pharma SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Erytech Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Erytech Pharma is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.
Janux Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Janux Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Janux Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Erytech Pharma and Janux Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Erytech Pharma and Janux Therapeutics

The main advantage of trading using opposite Erytech Pharma and Janux Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erytech Pharma position performs unexpectedly, Janux Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Janux Therapeutics will offset losses from the drop in Janux Therapeutics' long position.
The idea behind Erytech Pharma SA and Janux Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine